Böhler T - Search Results

1

Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCR.

Herr I, Balemans L, Böhler T, Walczak H, Debatin KM. Herr I, et al. Among authors: bohler t. Cell Death Differ. 1996 Jul;3(3):299-305. Cell Death Differ. 1996. PMID: 17180098

2

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM. Herr I, et al. Among authors: bohler t. EMBO J. 1997 Oct 15;16(20):6200-8. doi: 10.1093/emboj/16.20.6200. EMBO J. 1997. PMID: 9321399 Free PMC article.

3

Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.

Stricker K, Knipping E, Böhler T, Benner A, Krammer PH, Debatin KM. Stricker K, et al. Among authors: bohler t. Cell Death Differ. 1998 Mar;5(3):222-30. doi: 10.1038/sj.cdd.4400332. Cell Death Differ. 1998. PMID: 10200468

4

Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children.

Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin KM. Bäumler CB, et al. Among authors: bohler t. Blood. 1996 Sep 1;88(5):1741-6. Blood. 1996. PMID: 8781430 Free article.

5

Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents.

Böhler T, Bäumler C, Herr I, Groll A, Kurz M, Debatin KM. Böhler T, et al. Pediatr Infect Dis J. 1997 Aug;16(8):754-9. doi: 10.1097/00006454-199708000-00005. Pediatr Infect Dis J. 1997. PMID: 9271036

6

CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.

Beltinger C, Kurz E, Böhler T, Schrappe M, Ludwig WD, Debatin KM. Beltinger C, et al. Among authors: bohler t. Blood. 1998 May 15;91(10):3943-51. Blood. 1998. PMID: 9573033 Free article.

7

[The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].

Beltinger C, Böhler T, Schrappe M, Ludwig WD, Debatin KM. Beltinger C, et al. Among authors: bohler t. Klin Padiatr. 1998 Jul-Aug;210(4):153-8. doi: 10.1055/s-2008-1043871. Klin Padiatr. 1998. PMID: 9743945 Review. German.

8

JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha.

Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM. Herr I, et al. Among authors: bohler t. Int J Cancer. 1999 Jan 29;80(3):417-24. doi: 10.1002/(sici)1097-0215(19990129)80:3<417::aid-ijc14>3.0.co;2-b. Int J Cancer. 1999. PMID: 9935184

9

Lymphohematopoiesis in health and diseaseedited by Nydia G. Testa, Brian I. Lord, T. Michael Dexter.

Böhler T, Stahnke K, Debatin KM. Böhler T, et al. Cell Death Differ. 1998 Apr;5(4):340-341. doi: 10.1038/sj.cdd.4400350. Cell Death Differ. 1998. PMID: 10200481 No abstract available.

10

mAb33 from transduction laboratories specifically binds human CD95-L.

Herr I, Posovsky C, Böhler T, Debatin KM. Herr I, et al. Among authors: bohler t. Cell Death Differ. 2000 Jan;7(1):129-30. doi: 10.1038/sj.cdd.4400623. Cell Death Differ. 2000. PMID: 10858072 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters